Global DNA Repair Drugs Market Research Report 2024(Status and Outlook)
Report Overview:
DNA damage leads to the incorporation of defects and aberrations in the genome that often result in functional mutations. When these mutations occur in genes coding for vital proteins and/or enzymes, it leads to the development of genetic diseases. However, our biological system is equipped with a robust repair mechanism capable of correcting damaged DNA sequences. PARP inhibitors and other similar therapeutics are designed to augment the body’s innate DNA repair mechanism and aid in the treatment of diseases associated with genetic aberrations.
The Global DNA Repair Drugs Market Size was estimated at USD 725.06 million in 2023 and is projected to reach USD 1997.49 million by 2029, exhibiting a CAGR of 18.40% during the forecast period.
This report provides a deep insight into the global DNA Repair Drugs market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, Porter’s five forces analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global DNA Repair Drugs Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the DNA Repair Drugs market in any manner.
Global DNA Repair Drugs Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
4SC AG
ARCAGY/ GINECO GROUP
Bristol Myers Squibb
British Columbia Cancer Agency
Cambridge University Hospitals NHS Foundation Trust
Genentech
Georgetown University
German Breast Group
GlaxoSmithKline
Jiangsu Hengrui Medicine
Johnson & Johnson
Jonsson Comprehensive Cancer Center
Karyopharm Therapeutics
KuDOS Pharmaceuticals
National Health Service
National Institutes of Health
Tesaro
Market Segmentation (by Type)
PARP Inhibitors
Other
Market Segmentation (by Application)
Oncological
Stroke
Geographic Segmentation
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Note: this report may need to undergo a final check or review and this could take about 48 hours.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the DNA Repair Drugs Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the Market's Competitive Landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.
Chapter 12 is the main points and conclusions of the report.
DNA damage leads to the incorporation of defects and aberrations in the genome that often result in functional mutations. When these mutations occur in genes coding for vital proteins and/or enzymes, it leads to the development of genetic diseases. However, our biological system is equipped with a robust repair mechanism capable of correcting damaged DNA sequences. PARP inhibitors and other similar therapeutics are designed to augment the body’s innate DNA repair mechanism and aid in the treatment of diseases associated with genetic aberrations.
The Global DNA Repair Drugs Market Size was estimated at USD 725.06 million in 2023 and is projected to reach USD 1997.49 million by 2029, exhibiting a CAGR of 18.40% during the forecast period.
This report provides a deep insight into the global DNA Repair Drugs market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, Porter’s five forces analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global DNA Repair Drugs Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the DNA Repair Drugs market in any manner.
Global DNA Repair Drugs Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
4SC AG
ARCAGY/ GINECO GROUP
Bristol Myers Squibb
British Columbia Cancer Agency
Cambridge University Hospitals NHS Foundation Trust
Genentech
Georgetown University
German Breast Group
GlaxoSmithKline
Jiangsu Hengrui Medicine
Johnson & Johnson
Jonsson Comprehensive Cancer Center
Karyopharm Therapeutics
KuDOS Pharmaceuticals
National Health Service
National Institutes of Health
Tesaro
Market Segmentation (by Type)
PARP Inhibitors
Other
Market Segmentation (by Application)
Oncological
Stroke
Geographic Segmentation
- North America (USA, Canada, Mexico)
- Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
- South America (Brazil, Argentina, Columbia, Rest of South America)
- The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
- Industry drivers, restraints, and opportunities covered in the study
- Neutral perspective on the market performance
- Recent industry trends and developments
- Competitive landscape & strategies of key players
- Potential & niche segments and regions exhibiting promising growth covered
- Historical, current, and projected market size, in terms of value
- In-depth analysis of the DNA Repair Drugs Market
- Overview of the regional outlook of the DNA Repair Drugs Market:
- Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
- This enables you to anticipate market changes to remain ahead of your competitors
- You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
- The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
- Provision of market value (USD Billion) data for each segment and sub-segment
- Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
- Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
- Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
- Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
- The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
- Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
- Provides insight into the market through Value Chain
- Market dynamics scenario, along with growth opportunities of the market in the years to come
- 6-month post-sales analyst support
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Note: this report may need to undergo a final check or review and this could take about 48 hours.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the DNA Repair Drugs Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the Market's Competitive Landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.
Chapter 12 is the main points and conclusions of the report.
1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE
1.1 Market Definition and Statistical Scope of DNA Repair Drugs
1.2 Key Market Segments
1.2.1 DNA Repair Drugs Segment by Type
1.2.2 DNA Repair Drugs Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 DNA REPAIR DRUGS MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global DNA Repair Drugs Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global DNA Repair Drugs Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 DNA REPAIR DRUGS MARKET COMPETITIVE LANDSCAPE
3.1 Global DNA Repair Drugs Sales by Manufacturers (2019-2024)
3.2 Global DNA Repair Drugs Revenue Market Share by Manufacturers (2019-2024)
3.3 DNA Repair Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global DNA Repair Drugs Average Price by Manufacturers (2019-2024)
3.5 Manufacturers DNA Repair Drugs Sales Sites, Area Served, Product Type
3.6 DNA Repair Drugs Market Competitive Situation and Trends
3.6.1 DNA Repair Drugs Market Concentration Rate
3.6.2 Global 5 and 10 Largest DNA Repair Drugs Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 DNA REPAIR DRUGS INDUSTRY CHAIN ANALYSIS
4.1 DNA Repair Drugs Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF DNA REPAIR DRUGS MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 DNA REPAIR DRUGS MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global DNA Repair Drugs Sales Market Share by Type (2019-2024)
6.3 Global DNA Repair Drugs Market Size Market Share by Type (2019-2024)
6.4 Global DNA Repair Drugs Price by Type (2019-2024)
7 DNA REPAIR DRUGS MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global DNA Repair Drugs Market Sales by Application (2019-2024)
7.3 Global DNA Repair Drugs Market Size (M USD) by Application (2019-2024)
7.4 Global DNA Repair Drugs Sales Growth Rate by Application (2019-2024)
8 DNA REPAIR DRUGS MARKET SEGMENTATION BY REGION
8.1 Global DNA Repair Drugs Sales by Region
8.1.1 Global DNA Repair Drugs Sales by Region
8.1.2 Global DNA Repair Drugs Sales Market Share by Region
8.2 North America
8.2.1 North America DNA Repair Drugs Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe DNA Repair Drugs Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific DNA Repair Drugs Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America DNA Repair Drugs Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa DNA Repair Drugs Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 KEY COMPANIES PROFILE
9.1 4SC AG
9.1.1 4SC AG DNA Repair Drugs Basic Information
9.1.2 4SC AG DNA Repair Drugs Product Overview
9.1.3 4SC AG DNA Repair Drugs Product Market Performance
9.1.4 4SC AG Business Overview
9.1.5 4SC AG DNA Repair Drugs SWOT Analysis
9.1.6 4SC AG Recent Developments
9.2 ARCAGY/ GINECO GROUP
9.2.1 ARCAGY/ GINECO GROUP DNA Repair Drugs Basic Information
9.2.2 ARCAGY/ GINECO GROUP DNA Repair Drugs Product Overview
9.2.3 ARCAGY/ GINECO GROUP DNA Repair Drugs Product Market Performance
9.2.4 ARCAGY/ GINECO GROUP Business Overview
9.2.5 ARCAGY/ GINECO GROUP DNA Repair Drugs SWOT Analysis
9.2.6 ARCAGY/ GINECO GROUP Recent Developments
9.3 Bristol Myers Squibb
9.3.1 Bristol Myers Squibb DNA Repair Drugs Basic Information
9.3.2 Bristol Myers Squibb DNA Repair Drugs Product Overview
9.3.3 Bristol Myers Squibb DNA Repair Drugs Product Market Performance
9.3.4 Bristol Myers Squibb DNA Repair Drugs SWOT Analysis
9.3.5 Bristol Myers Squibb Business Overview
9.3.6 Bristol Myers Squibb Recent Developments
9.4 British Columbia Cancer Agency
9.4.1 British Columbia Cancer Agency DNA Repair Drugs Basic Information
9.4.2 British Columbia Cancer Agency DNA Repair Drugs Product Overview
9.4.3 British Columbia Cancer Agency DNA Repair Drugs Product Market Performance
9.4.4 British Columbia Cancer Agency Business Overview
9.4.5 British Columbia Cancer Agency Recent Developments
9.5 Cambridge University Hospitals NHS Foundation Trust
9.5.1 Cambridge University Hospitals NHS Foundation Trust DNA Repair Drugs Basic Information
9.5.2 Cambridge University Hospitals NHS Foundation Trust DNA Repair Drugs Product Overview
9.5.3 Cambridge University Hospitals NHS Foundation Trust DNA Repair Drugs Product Market Performance
9.5.4 Cambridge University Hospitals NHS Foundation Trust Business Overview
9.5.5 Cambridge University Hospitals NHS Foundation Trust Recent Developments
9.6 Genentech
9.6.1 Genentech DNA Repair Drugs Basic Information
9.6.2 Genentech DNA Repair Drugs Product Overview
9.6.3 Genentech DNA Repair Drugs Product Market Performance
9.6.4 Genentech Business Overview
9.6.5 Genentech Recent Developments
9.7 Georgetown University
9.7.1 Georgetown University DNA Repair Drugs Basic Information
9.7.2 Georgetown University DNA Repair Drugs Product Overview
9.7.3 Georgetown University DNA Repair Drugs Product Market Performance
9.7.4 Georgetown University Business Overview
9.7.5 Georgetown University Recent Developments
9.8 German Breast Group
9.8.1 German Breast Group DNA Repair Drugs Basic Information
9.8.2 German Breast Group DNA Repair Drugs Product Overview
9.8.3 German Breast Group DNA Repair Drugs Product Market Performance
9.8.4 German Breast Group Business Overview
9.8.5 German Breast Group Recent Developments
9.9 GlaxoSmithKline
9.9.1 GlaxoSmithKline DNA Repair Drugs Basic Information
9.9.2 GlaxoSmithKline DNA Repair Drugs Product Overview
9.9.3 GlaxoSmithKline DNA Repair Drugs Product Market Performance
9.9.4 GlaxoSmithKline Business Overview
9.9.5 GlaxoSmithKline Recent Developments
9.10 Jiangsu Hengrui Medicine
9.10.1 Jiangsu Hengrui Medicine DNA Repair Drugs Basic Information
9.10.2 Jiangsu Hengrui Medicine DNA Repair Drugs Product Overview
9.10.3 Jiangsu Hengrui Medicine DNA Repair Drugs Product Market Performance
9.10.4 Jiangsu Hengrui Medicine Business Overview
9.10.5 Jiangsu Hengrui Medicine Recent Developments
9.11 Johnson and Johnson
9.11.1 Johnson and Johnson DNA Repair Drugs Basic Information
9.11.2 Johnson and Johnson DNA Repair Drugs Product Overview
9.11.3 Johnson and Johnson DNA Repair Drugs Product Market Performance
9.11.4 Johnson and Johnson Business Overview
9.11.5 Johnson and Johnson Recent Developments
9.12 Jonsson Comprehensive Cancer Center
9.12.1 Jonsson Comprehensive Cancer Center DNA Repair Drugs Basic Information
9.12.2 Jonsson Comprehensive Cancer Center DNA Repair Drugs Product Overview
9.12.3 Jonsson Comprehensive Cancer Center DNA Repair Drugs Product Market Performance
9.12.4 Jonsson Comprehensive Cancer Center Business Overview
9.12.5 Jonsson Comprehensive Cancer Center Recent Developments
9.13 Karyopharm Therapeutics
9.13.1 Karyopharm Therapeutics DNA Repair Drugs Basic Information
9.13.2 Karyopharm Therapeutics DNA Repair Drugs Product Overview
9.13.3 Karyopharm Therapeutics DNA Repair Drugs Product Market Performance
9.13.4 Karyopharm Therapeutics Business Overview
9.13.5 Karyopharm Therapeutics Recent Developments
9.14 KuDOS Pharmaceuticals
9.14.1 KuDOS Pharmaceuticals DNA Repair Drugs Basic Information
9.14.2 KuDOS Pharmaceuticals DNA Repair Drugs Product Overview
9.14.3 KuDOS Pharmaceuticals DNA Repair Drugs Product Market Performance
9.14.4 KuDOS Pharmaceuticals Business Overview
9.14.5 KuDOS Pharmaceuticals Recent Developments
9.15 National Health Service
9.15.1 National Health Service DNA Repair Drugs Basic Information
9.15.2 National Health Service DNA Repair Drugs Product Overview
9.15.3 National Health Service DNA Repair Drugs Product Market Performance
9.15.4 National Health Service Business Overview
9.15.5 National Health Service Recent Developments
9.16 National Institutes of Health
9.16.1 National Institutes of Health DNA Repair Drugs Basic Information
9.16.2 National Institutes of Health DNA Repair Drugs Product Overview
9.16.3 National Institutes of Health DNA Repair Drugs Product Market Performance
9.16.4 National Institutes of Health Business Overview
9.16.5 National Institutes of Health Recent Developments
9.17 Tesaro
9.17.1 Tesaro DNA Repair Drugs Basic Information
9.17.2 Tesaro DNA Repair Drugs Product Overview
9.17.3 Tesaro DNA Repair Drugs Product Market Performance
9.17.4 Tesaro Business Overview
9.17.5 Tesaro Recent Developments
10 DNA REPAIR DRUGS MARKET FORECAST BY REGION
10.1 Global DNA Repair Drugs Market Size Forecast
10.2 Global DNA Repair Drugs Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe DNA Repair Drugs Market Size Forecast by Country
10.2.3 Asia Pacific DNA Repair Drugs Market Size Forecast by Region
10.2.4 South America DNA Repair Drugs Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of DNA Repair Drugs by Country
11 FORECAST MARKET BY TYPE AND BY APPLICATION (2025-2030)
11.1 Global DNA Repair Drugs Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of DNA Repair Drugs by Type (2025-2030)
11.1.2 Global DNA Repair Drugs Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of DNA Repair Drugs by Type (2025-2030)
11.2 Global DNA Repair Drugs Market Forecast by Application (2025-2030)
11.2.1 Global DNA Repair Drugs Sales (Kilotons) Forecast by Application
11.2.2 Global DNA Repair Drugs Market Size (M USD) Forecast by Application (2025-2030)
12 CONCLUSION AND KEY FINDINGS
1.1 Market Definition and Statistical Scope of DNA Repair Drugs
1.2 Key Market Segments
1.2.1 DNA Repair Drugs Segment by Type
1.2.2 DNA Repair Drugs Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 DNA REPAIR DRUGS MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global DNA Repair Drugs Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global DNA Repair Drugs Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 DNA REPAIR DRUGS MARKET COMPETITIVE LANDSCAPE
3.1 Global DNA Repair Drugs Sales by Manufacturers (2019-2024)
3.2 Global DNA Repair Drugs Revenue Market Share by Manufacturers (2019-2024)
3.3 DNA Repair Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global DNA Repair Drugs Average Price by Manufacturers (2019-2024)
3.5 Manufacturers DNA Repair Drugs Sales Sites, Area Served, Product Type
3.6 DNA Repair Drugs Market Competitive Situation and Trends
3.6.1 DNA Repair Drugs Market Concentration Rate
3.6.2 Global 5 and 10 Largest DNA Repair Drugs Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 DNA REPAIR DRUGS INDUSTRY CHAIN ANALYSIS
4.1 DNA Repair Drugs Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF DNA REPAIR DRUGS MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 DNA REPAIR DRUGS MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global DNA Repair Drugs Sales Market Share by Type (2019-2024)
6.3 Global DNA Repair Drugs Market Size Market Share by Type (2019-2024)
6.4 Global DNA Repair Drugs Price by Type (2019-2024)
7 DNA REPAIR DRUGS MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global DNA Repair Drugs Market Sales by Application (2019-2024)
7.3 Global DNA Repair Drugs Market Size (M USD) by Application (2019-2024)
7.4 Global DNA Repair Drugs Sales Growth Rate by Application (2019-2024)
8 DNA REPAIR DRUGS MARKET SEGMENTATION BY REGION
8.1 Global DNA Repair Drugs Sales by Region
8.1.1 Global DNA Repair Drugs Sales by Region
8.1.2 Global DNA Repair Drugs Sales Market Share by Region
8.2 North America
8.2.1 North America DNA Repair Drugs Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe DNA Repair Drugs Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific DNA Repair Drugs Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America DNA Repair Drugs Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa DNA Repair Drugs Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 KEY COMPANIES PROFILE
9.1 4SC AG
9.1.1 4SC AG DNA Repair Drugs Basic Information
9.1.2 4SC AG DNA Repair Drugs Product Overview
9.1.3 4SC AG DNA Repair Drugs Product Market Performance
9.1.4 4SC AG Business Overview
9.1.5 4SC AG DNA Repair Drugs SWOT Analysis
9.1.6 4SC AG Recent Developments
9.2 ARCAGY/ GINECO GROUP
9.2.1 ARCAGY/ GINECO GROUP DNA Repair Drugs Basic Information
9.2.2 ARCAGY/ GINECO GROUP DNA Repair Drugs Product Overview
9.2.3 ARCAGY/ GINECO GROUP DNA Repair Drugs Product Market Performance
9.2.4 ARCAGY/ GINECO GROUP Business Overview
9.2.5 ARCAGY/ GINECO GROUP DNA Repair Drugs SWOT Analysis
9.2.6 ARCAGY/ GINECO GROUP Recent Developments
9.3 Bristol Myers Squibb
9.3.1 Bristol Myers Squibb DNA Repair Drugs Basic Information
9.3.2 Bristol Myers Squibb DNA Repair Drugs Product Overview
9.3.3 Bristol Myers Squibb DNA Repair Drugs Product Market Performance
9.3.4 Bristol Myers Squibb DNA Repair Drugs SWOT Analysis
9.3.5 Bristol Myers Squibb Business Overview
9.3.6 Bristol Myers Squibb Recent Developments
9.4 British Columbia Cancer Agency
9.4.1 British Columbia Cancer Agency DNA Repair Drugs Basic Information
9.4.2 British Columbia Cancer Agency DNA Repair Drugs Product Overview
9.4.3 British Columbia Cancer Agency DNA Repair Drugs Product Market Performance
9.4.4 British Columbia Cancer Agency Business Overview
9.4.5 British Columbia Cancer Agency Recent Developments
9.5 Cambridge University Hospitals NHS Foundation Trust
9.5.1 Cambridge University Hospitals NHS Foundation Trust DNA Repair Drugs Basic Information
9.5.2 Cambridge University Hospitals NHS Foundation Trust DNA Repair Drugs Product Overview
9.5.3 Cambridge University Hospitals NHS Foundation Trust DNA Repair Drugs Product Market Performance
9.5.4 Cambridge University Hospitals NHS Foundation Trust Business Overview
9.5.5 Cambridge University Hospitals NHS Foundation Trust Recent Developments
9.6 Genentech
9.6.1 Genentech DNA Repair Drugs Basic Information
9.6.2 Genentech DNA Repair Drugs Product Overview
9.6.3 Genentech DNA Repair Drugs Product Market Performance
9.6.4 Genentech Business Overview
9.6.5 Genentech Recent Developments
9.7 Georgetown University
9.7.1 Georgetown University DNA Repair Drugs Basic Information
9.7.2 Georgetown University DNA Repair Drugs Product Overview
9.7.3 Georgetown University DNA Repair Drugs Product Market Performance
9.7.4 Georgetown University Business Overview
9.7.5 Georgetown University Recent Developments
9.8 German Breast Group
9.8.1 German Breast Group DNA Repair Drugs Basic Information
9.8.2 German Breast Group DNA Repair Drugs Product Overview
9.8.3 German Breast Group DNA Repair Drugs Product Market Performance
9.8.4 German Breast Group Business Overview
9.8.5 German Breast Group Recent Developments
9.9 GlaxoSmithKline
9.9.1 GlaxoSmithKline DNA Repair Drugs Basic Information
9.9.2 GlaxoSmithKline DNA Repair Drugs Product Overview
9.9.3 GlaxoSmithKline DNA Repair Drugs Product Market Performance
9.9.4 GlaxoSmithKline Business Overview
9.9.5 GlaxoSmithKline Recent Developments
9.10 Jiangsu Hengrui Medicine
9.10.1 Jiangsu Hengrui Medicine DNA Repair Drugs Basic Information
9.10.2 Jiangsu Hengrui Medicine DNA Repair Drugs Product Overview
9.10.3 Jiangsu Hengrui Medicine DNA Repair Drugs Product Market Performance
9.10.4 Jiangsu Hengrui Medicine Business Overview
9.10.5 Jiangsu Hengrui Medicine Recent Developments
9.11 Johnson and Johnson
9.11.1 Johnson and Johnson DNA Repair Drugs Basic Information
9.11.2 Johnson and Johnson DNA Repair Drugs Product Overview
9.11.3 Johnson and Johnson DNA Repair Drugs Product Market Performance
9.11.4 Johnson and Johnson Business Overview
9.11.5 Johnson and Johnson Recent Developments
9.12 Jonsson Comprehensive Cancer Center
9.12.1 Jonsson Comprehensive Cancer Center DNA Repair Drugs Basic Information
9.12.2 Jonsson Comprehensive Cancer Center DNA Repair Drugs Product Overview
9.12.3 Jonsson Comprehensive Cancer Center DNA Repair Drugs Product Market Performance
9.12.4 Jonsson Comprehensive Cancer Center Business Overview
9.12.5 Jonsson Comprehensive Cancer Center Recent Developments
9.13 Karyopharm Therapeutics
9.13.1 Karyopharm Therapeutics DNA Repair Drugs Basic Information
9.13.2 Karyopharm Therapeutics DNA Repair Drugs Product Overview
9.13.3 Karyopharm Therapeutics DNA Repair Drugs Product Market Performance
9.13.4 Karyopharm Therapeutics Business Overview
9.13.5 Karyopharm Therapeutics Recent Developments
9.14 KuDOS Pharmaceuticals
9.14.1 KuDOS Pharmaceuticals DNA Repair Drugs Basic Information
9.14.2 KuDOS Pharmaceuticals DNA Repair Drugs Product Overview
9.14.3 KuDOS Pharmaceuticals DNA Repair Drugs Product Market Performance
9.14.4 KuDOS Pharmaceuticals Business Overview
9.14.5 KuDOS Pharmaceuticals Recent Developments
9.15 National Health Service
9.15.1 National Health Service DNA Repair Drugs Basic Information
9.15.2 National Health Service DNA Repair Drugs Product Overview
9.15.3 National Health Service DNA Repair Drugs Product Market Performance
9.15.4 National Health Service Business Overview
9.15.5 National Health Service Recent Developments
9.16 National Institutes of Health
9.16.1 National Institutes of Health DNA Repair Drugs Basic Information
9.16.2 National Institutes of Health DNA Repair Drugs Product Overview
9.16.3 National Institutes of Health DNA Repair Drugs Product Market Performance
9.16.4 National Institutes of Health Business Overview
9.16.5 National Institutes of Health Recent Developments
9.17 Tesaro
9.17.1 Tesaro DNA Repair Drugs Basic Information
9.17.2 Tesaro DNA Repair Drugs Product Overview
9.17.3 Tesaro DNA Repair Drugs Product Market Performance
9.17.4 Tesaro Business Overview
9.17.5 Tesaro Recent Developments
10 DNA REPAIR DRUGS MARKET FORECAST BY REGION
10.1 Global DNA Repair Drugs Market Size Forecast
10.2 Global DNA Repair Drugs Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe DNA Repair Drugs Market Size Forecast by Country
10.2.3 Asia Pacific DNA Repair Drugs Market Size Forecast by Region
10.2.4 South America DNA Repair Drugs Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of DNA Repair Drugs by Country
11 FORECAST MARKET BY TYPE AND BY APPLICATION (2025-2030)
11.1 Global DNA Repair Drugs Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of DNA Repair Drugs by Type (2025-2030)
11.1.2 Global DNA Repair Drugs Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of DNA Repair Drugs by Type (2025-2030)
11.2 Global DNA Repair Drugs Market Forecast by Application (2025-2030)
11.2.1 Global DNA Repair Drugs Sales (Kilotons) Forecast by Application
11.2.2 Global DNA Repair Drugs Market Size (M USD) Forecast by Application (2025-2030)
12 CONCLUSION AND KEY FINDINGS
LIST OF TABLES
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. DNA Repair Drugs Market Size Comparison by Region (M USD)
Table 5. Global DNA Repair Drugs Sales (Kilotons) by Manufacturers (2019-2024)
Table 6. Global DNA Repair Drugs Sales Market Share by Manufacturers (2019-2024)
Table 7. Global DNA Repair Drugs Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global DNA Repair Drugs Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in DNA Repair Drugs as of 2022)
Table 10. Global Market DNA Repair Drugs Average Price (USD/Ton) of Key Manufacturers (2019-2024)
Table 11. Manufacturers DNA Repair Drugs Sales Sites and Area Served
Table 12. Manufacturers DNA Repair Drugs Product Type
Table 13. Global DNA Repair Drugs Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of DNA Repair Drugs
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. DNA Repair Drugs Market Challenges
Table 22. Global DNA Repair Drugs Sales by Type (Kilotons)
Table 23. Global DNA Repair Drugs Market Size by Type (M USD)
Table 24. Global DNA Repair Drugs Sales (Kilotons) by Type (2019-2024)
Table 25. Global DNA Repair Drugs Sales Market Share by Type (2019-2024)
Table 26. Global DNA Repair Drugs Market Size (M USD) by Type (2019-2024)
Table 27. Global DNA Repair Drugs Market Size Share by Type (2019-2024)
Table 28. Global DNA Repair Drugs Price (USD/Ton) by Type (2019-2024)
Table 29. Global DNA Repair Drugs Sales (Kilotons) by Application
Table 30. Global DNA Repair Drugs Market Size by Application
Table 31. Global DNA Repair Drugs Sales by Application (2019-2024) & (Kilotons)
Table 32. Global DNA Repair Drugs Sales Market Share by Application (2019-2024)
Table 33. Global DNA Repair Drugs Sales by Application (2019-2024) & (M USD)
Table 34. Global DNA Repair Drugs Market Share by Application (2019-2024)
Table 35. Global DNA Repair Drugs Sales Growth Rate by Application (2019-2024)
Table 36. Global DNA Repair Drugs Sales by Region (2019-2024) & (Kilotons)
Table 37. Global DNA Repair Drugs Sales Market Share by Region (2019-2024)
Table 38. North America DNA Repair Drugs Sales by Country (2019-2024) & (Kilotons)
Table 39. Europe DNA Repair Drugs Sales by Country (2019-2024) & (Kilotons)
Table 40. Asia Pacific DNA Repair Drugs Sales by Region (2019-2024) & (Kilotons)
Table 41. South America DNA Repair Drugs Sales by Country (2019-2024) & (Kilotons)
Table 42. Middle East and Africa DNA Repair Drugs Sales by Region (2019-2024) & (Kilotons)
Table 43. 4SC AG DNA Repair Drugs Basic Information
Table 44. 4SC AG DNA Repair Drugs Product Overview
Table 45. 4SC AG DNA Repair Drugs Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 46. 4SC AG Business Overview
Table 47. 4SC AG DNA Repair Drugs SWOT Analysis
Table 48. 4SC AG Recent Developments
Table 49. ARCAGY/ GINECO GROUP DNA Repair Drugs Basic Information
Table 50. ARCAGY/ GINECO GROUP DNA Repair Drugs Product Overview
Table 51. ARCAGY/ GINECO GROUP DNA Repair Drugs Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 52. ARCAGY/ GINECO GROUP Business Overview
Table 53. ARCAGY/ GINECO GROUP DNA Repair Drugs SWOT Analysis
Table 54. ARCAGY/ GINECO GROUP Recent Developments
Table 55. Bristol Myers Squibb DNA Repair Drugs Basic Information
Table 56. Bristol Myers Squibb DNA Repair Drugs Product Overview
Table 57. Bristol Myers Squibb DNA Repair Drugs Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 58. Bristol Myers Squibb DNA Repair Drugs SWOT Analysis
Table 59. Bristol Myers Squibb Business Overview
Table 60. Bristol Myers Squibb Recent Developments
Table 61. British Columbia Cancer Agency DNA Repair Drugs Basic Information
Table 62. British Columbia Cancer Agency DNA Repair Drugs Product Overview
Table 63. British Columbia Cancer Agency DNA Repair Drugs Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 64. British Columbia Cancer Agency Business Overview
Table 65. British Columbia Cancer Agency Recent Developments
Table 66. Cambridge University Hospitals NHS Foundation Trust DNA Repair Drugs Basic Information
Table 67. Cambridge University Hospitals NHS Foundation Trust DNA Repair Drugs Product Overview
Table 68. Cambridge University Hospitals NHS Foundation Trust DNA Repair Drugs Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 69. Cambridge University Hospitals NHS Foundation Trust Business Overview
Table 70. Cambridge University Hospitals NHS Foundation Trust Recent Developments
Table 71. Genentech DNA Repair Drugs Basic Information
Table 72. Genentech DNA Repair Drugs Product Overview
Table 73. Genentech DNA Repair Drugs Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 74. Genentech Business Overview
Table 75. Genentech Recent Developments
Table 76. Georgetown University DNA Repair Drugs Basic Information
Table 77. Georgetown University DNA Repair Drugs Product Overview
Table 78. Georgetown University DNA Repair Drugs Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 79. Georgetown University Business Overview
Table 80. Georgetown University Recent Developments
Table 81. German Breast Group DNA Repair Drugs Basic Information
Table 82. German Breast Group DNA Repair Drugs Product Overview
Table 83. German Breast Group DNA Repair Drugs Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 84. German Breast Group Business Overview
Table 85. German Breast Group Recent Developments
Table 86. GlaxoSmithKline DNA Repair Drugs Basic Information
Table 87. GlaxoSmithKline DNA Repair Drugs Product Overview
Table 88. GlaxoSmithKline DNA Repair Drugs Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 89. GlaxoSmithKline Business Overview
Table 90. GlaxoSmithKline Recent Developments
Table 91. Jiangsu Hengrui Medicine DNA Repair Drugs Basic Information
Table 92. Jiangsu Hengrui Medicine DNA Repair Drugs Product Overview
Table 93. Jiangsu Hengrui Medicine DNA Repair Drugs Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 94. Jiangsu Hengrui Medicine Business Overview
Table 95. Jiangsu Hengrui Medicine Recent Developments
Table 96. Johnson and Johnson DNA Repair Drugs Basic Information
Table 97. Johnson and Johnson DNA Repair Drugs Product Overview
Table 98. Johnson and Johnson DNA Repair Drugs Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 99. Johnson and Johnson Business Overview
Table 100. Johnson and Johnson Recent Developments
Table 101. Jonsson Comprehensive Cancer Center DNA Repair Drugs Basic Information
Table 102. Jonsson Comprehensive Cancer Center DNA Repair Drugs Product Overview
Table 103. Jonsson Comprehensive Cancer Center DNA Repair Drugs Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 104. Jonsson Comprehensive Cancer Center Business Overview
Table 105. Jonsson Comprehensive Cancer Center Recent Developments
Table 106. Karyopharm Therapeutics DNA Repair Drugs Basic Information
Table 107. Karyopharm Therapeutics DNA Repair Drugs Product Overview
Table 108. Karyopharm Therapeutics DNA Repair Drugs Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 109. Karyopharm Therapeutics Business Overview
Table 110. Karyopharm Therapeutics Recent Developments
Table 111. KuDOS Pharmaceuticals DNA Repair Drugs Basic Information
Table 112. KuDOS Pharmaceuticals DNA Repair Drugs Product Overview
Table 113. KuDOS Pharmaceuticals DNA Repair Drugs Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 114. KuDOS Pharmaceuticals Business Overview
Table 115. KuDOS Pharmaceuticals Recent Developments
Table 116. National Health Service DNA Repair Drugs Basic Information
Table 117. National Health Service DNA Repair Drugs Product Overview
Table 118. National Health Service DNA Repair Drugs Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 119. National Health Service Business Overview
Table 120. National Health Service Recent Developments
Table 121. National Institutes of Health DNA Repair Drugs Basic Information
Table 122. National Institutes of Health DNA Repair Drugs Product Overview
Table 123. National Institutes of Health DNA Repair Drugs Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 124. National Institutes of Health Business Overview
Table 125. National Institutes of Health Recent Developments
Table 126. Tesaro DNA Repair Drugs Basic Information
Table 127. Tesaro DNA Repair Drugs Product Overview
Table 128. Tesaro DNA Repair Drugs Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 129. Tesaro Business Overview
Table 130. Tesaro Recent Developments
Table 131. Global DNA Repair Drugs Sales Forecast by Region (2025-2030) & (Kilotons)
Table 132. Global DNA Repair Drugs Market Size Forecast by Region (2025-2030) & (M USD)
Table 133. North America DNA Repair Drugs Sales Forecast by Country (2025-2030) & (Kilotons)
Table 134. North America DNA Repair Drugs Market Size Forecast by Country (2025-2030) & (M USD)
Table 135. Europe DNA Repair Drugs Sales Forecast by Country (2025-2030) & (Kilotons)
Table 136. Europe DNA Repair Drugs Market Size Forecast by Country (2025-2030) & (M USD)
Table 137. Asia Pacific DNA Repair Drugs Sales Forecast by Region (2025-2030) & (Kilotons)
Table 138. Asia Pacific DNA Repair Drugs Market Size Forecast by Region (2025-2030) & (M USD)
Table 139. South America DNA Repair Drugs Sales Forecast by Country (2025-2030) & (Kilotons)
Table 140. South America DNA Repair Drugs Market Size Forecast by Country (2025-2030) & (M USD)
Table 141. Middle East and Africa DNA Repair Drugs Consumption Forecast by Country (2025-2030) & (Units)
Table 142. Middle East and Africa DNA Repair Drugs Market Size Forecast by Country (2025-2030) & (M USD)
Table 143. Global DNA Repair Drugs Sales Forecast by Type (2025-2030) & (Kilotons)
Table 144. Global DNA Repair Drugs Market Size Forecast by Type (2025-2030) & (M USD)
Table 145. Global DNA Repair Drugs Price Forecast by Type (2025-2030) & (USD/Ton)
Table 146. Global DNA Repair Drugs Sales (Kilotons) Forecast by Application (2025-2030)
Table 147. Global DNA Repair Drugs Market Size Forecast by Application (2025-2030) & (M USD)
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. DNA Repair Drugs Market Size Comparison by Region (M USD)
Table 5. Global DNA Repair Drugs Sales (Kilotons) by Manufacturers (2019-2024)
Table 6. Global DNA Repair Drugs Sales Market Share by Manufacturers (2019-2024)
Table 7. Global DNA Repair Drugs Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global DNA Repair Drugs Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in DNA Repair Drugs as of 2022)
Table 10. Global Market DNA Repair Drugs Average Price (USD/Ton) of Key Manufacturers (2019-2024)
Table 11. Manufacturers DNA Repair Drugs Sales Sites and Area Served
Table 12. Manufacturers DNA Repair Drugs Product Type
Table 13. Global DNA Repair Drugs Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of DNA Repair Drugs
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. DNA Repair Drugs Market Challenges
Table 22. Global DNA Repair Drugs Sales by Type (Kilotons)
Table 23. Global DNA Repair Drugs Market Size by Type (M USD)
Table 24. Global DNA Repair Drugs Sales (Kilotons) by Type (2019-2024)
Table 25. Global DNA Repair Drugs Sales Market Share by Type (2019-2024)
Table 26. Global DNA Repair Drugs Market Size (M USD) by Type (2019-2024)
Table 27. Global DNA Repair Drugs Market Size Share by Type (2019-2024)
Table 28. Global DNA Repair Drugs Price (USD/Ton) by Type (2019-2024)
Table 29. Global DNA Repair Drugs Sales (Kilotons) by Application
Table 30. Global DNA Repair Drugs Market Size by Application
Table 31. Global DNA Repair Drugs Sales by Application (2019-2024) & (Kilotons)
Table 32. Global DNA Repair Drugs Sales Market Share by Application (2019-2024)
Table 33. Global DNA Repair Drugs Sales by Application (2019-2024) & (M USD)
Table 34. Global DNA Repair Drugs Market Share by Application (2019-2024)
Table 35. Global DNA Repair Drugs Sales Growth Rate by Application (2019-2024)
Table 36. Global DNA Repair Drugs Sales by Region (2019-2024) & (Kilotons)
Table 37. Global DNA Repair Drugs Sales Market Share by Region (2019-2024)
Table 38. North America DNA Repair Drugs Sales by Country (2019-2024) & (Kilotons)
Table 39. Europe DNA Repair Drugs Sales by Country (2019-2024) & (Kilotons)
Table 40. Asia Pacific DNA Repair Drugs Sales by Region (2019-2024) & (Kilotons)
Table 41. South America DNA Repair Drugs Sales by Country (2019-2024) & (Kilotons)
Table 42. Middle East and Africa DNA Repair Drugs Sales by Region (2019-2024) & (Kilotons)
Table 43. 4SC AG DNA Repair Drugs Basic Information
Table 44. 4SC AG DNA Repair Drugs Product Overview
Table 45. 4SC AG DNA Repair Drugs Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 46. 4SC AG Business Overview
Table 47. 4SC AG DNA Repair Drugs SWOT Analysis
Table 48. 4SC AG Recent Developments
Table 49. ARCAGY/ GINECO GROUP DNA Repair Drugs Basic Information
Table 50. ARCAGY/ GINECO GROUP DNA Repair Drugs Product Overview
Table 51. ARCAGY/ GINECO GROUP DNA Repair Drugs Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 52. ARCAGY/ GINECO GROUP Business Overview
Table 53. ARCAGY/ GINECO GROUP DNA Repair Drugs SWOT Analysis
Table 54. ARCAGY/ GINECO GROUP Recent Developments
Table 55. Bristol Myers Squibb DNA Repair Drugs Basic Information
Table 56. Bristol Myers Squibb DNA Repair Drugs Product Overview
Table 57. Bristol Myers Squibb DNA Repair Drugs Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 58. Bristol Myers Squibb DNA Repair Drugs SWOT Analysis
Table 59. Bristol Myers Squibb Business Overview
Table 60. Bristol Myers Squibb Recent Developments
Table 61. British Columbia Cancer Agency DNA Repair Drugs Basic Information
Table 62. British Columbia Cancer Agency DNA Repair Drugs Product Overview
Table 63. British Columbia Cancer Agency DNA Repair Drugs Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 64. British Columbia Cancer Agency Business Overview
Table 65. British Columbia Cancer Agency Recent Developments
Table 66. Cambridge University Hospitals NHS Foundation Trust DNA Repair Drugs Basic Information
Table 67. Cambridge University Hospitals NHS Foundation Trust DNA Repair Drugs Product Overview
Table 68. Cambridge University Hospitals NHS Foundation Trust DNA Repair Drugs Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 69. Cambridge University Hospitals NHS Foundation Trust Business Overview
Table 70. Cambridge University Hospitals NHS Foundation Trust Recent Developments
Table 71. Genentech DNA Repair Drugs Basic Information
Table 72. Genentech DNA Repair Drugs Product Overview
Table 73. Genentech DNA Repair Drugs Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 74. Genentech Business Overview
Table 75. Genentech Recent Developments
Table 76. Georgetown University DNA Repair Drugs Basic Information
Table 77. Georgetown University DNA Repair Drugs Product Overview
Table 78. Georgetown University DNA Repair Drugs Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 79. Georgetown University Business Overview
Table 80. Georgetown University Recent Developments
Table 81. German Breast Group DNA Repair Drugs Basic Information
Table 82. German Breast Group DNA Repair Drugs Product Overview
Table 83. German Breast Group DNA Repair Drugs Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 84. German Breast Group Business Overview
Table 85. German Breast Group Recent Developments
Table 86. GlaxoSmithKline DNA Repair Drugs Basic Information
Table 87. GlaxoSmithKline DNA Repair Drugs Product Overview
Table 88. GlaxoSmithKline DNA Repair Drugs Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 89. GlaxoSmithKline Business Overview
Table 90. GlaxoSmithKline Recent Developments
Table 91. Jiangsu Hengrui Medicine DNA Repair Drugs Basic Information
Table 92. Jiangsu Hengrui Medicine DNA Repair Drugs Product Overview
Table 93. Jiangsu Hengrui Medicine DNA Repair Drugs Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 94. Jiangsu Hengrui Medicine Business Overview
Table 95. Jiangsu Hengrui Medicine Recent Developments
Table 96. Johnson and Johnson DNA Repair Drugs Basic Information
Table 97. Johnson and Johnson DNA Repair Drugs Product Overview
Table 98. Johnson and Johnson DNA Repair Drugs Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 99. Johnson and Johnson Business Overview
Table 100. Johnson and Johnson Recent Developments
Table 101. Jonsson Comprehensive Cancer Center DNA Repair Drugs Basic Information
Table 102. Jonsson Comprehensive Cancer Center DNA Repair Drugs Product Overview
Table 103. Jonsson Comprehensive Cancer Center DNA Repair Drugs Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 104. Jonsson Comprehensive Cancer Center Business Overview
Table 105. Jonsson Comprehensive Cancer Center Recent Developments
Table 106. Karyopharm Therapeutics DNA Repair Drugs Basic Information
Table 107. Karyopharm Therapeutics DNA Repair Drugs Product Overview
Table 108. Karyopharm Therapeutics DNA Repair Drugs Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 109. Karyopharm Therapeutics Business Overview
Table 110. Karyopharm Therapeutics Recent Developments
Table 111. KuDOS Pharmaceuticals DNA Repair Drugs Basic Information
Table 112. KuDOS Pharmaceuticals DNA Repair Drugs Product Overview
Table 113. KuDOS Pharmaceuticals DNA Repair Drugs Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 114. KuDOS Pharmaceuticals Business Overview
Table 115. KuDOS Pharmaceuticals Recent Developments
Table 116. National Health Service DNA Repair Drugs Basic Information
Table 117. National Health Service DNA Repair Drugs Product Overview
Table 118. National Health Service DNA Repair Drugs Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 119. National Health Service Business Overview
Table 120. National Health Service Recent Developments
Table 121. National Institutes of Health DNA Repair Drugs Basic Information
Table 122. National Institutes of Health DNA Repair Drugs Product Overview
Table 123. National Institutes of Health DNA Repair Drugs Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 124. National Institutes of Health Business Overview
Table 125. National Institutes of Health Recent Developments
Table 126. Tesaro DNA Repair Drugs Basic Information
Table 127. Tesaro DNA Repair Drugs Product Overview
Table 128. Tesaro DNA Repair Drugs Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 129. Tesaro Business Overview
Table 130. Tesaro Recent Developments
Table 131. Global DNA Repair Drugs Sales Forecast by Region (2025-2030) & (Kilotons)
Table 132. Global DNA Repair Drugs Market Size Forecast by Region (2025-2030) & (M USD)
Table 133. North America DNA Repair Drugs Sales Forecast by Country (2025-2030) & (Kilotons)
Table 134. North America DNA Repair Drugs Market Size Forecast by Country (2025-2030) & (M USD)
Table 135. Europe DNA Repair Drugs Sales Forecast by Country (2025-2030) & (Kilotons)
Table 136. Europe DNA Repair Drugs Market Size Forecast by Country (2025-2030) & (M USD)
Table 137. Asia Pacific DNA Repair Drugs Sales Forecast by Region (2025-2030) & (Kilotons)
Table 138. Asia Pacific DNA Repair Drugs Market Size Forecast by Region (2025-2030) & (M USD)
Table 139. South America DNA Repair Drugs Sales Forecast by Country (2025-2030) & (Kilotons)
Table 140. South America DNA Repair Drugs Market Size Forecast by Country (2025-2030) & (M USD)
Table 141. Middle East and Africa DNA Repair Drugs Consumption Forecast by Country (2025-2030) & (Units)
Table 142. Middle East and Africa DNA Repair Drugs Market Size Forecast by Country (2025-2030) & (M USD)
Table 143. Global DNA Repair Drugs Sales Forecast by Type (2025-2030) & (Kilotons)
Table 144. Global DNA Repair Drugs Market Size Forecast by Type (2025-2030) & (M USD)
Table 145. Global DNA Repair Drugs Price Forecast by Type (2025-2030) & (USD/Ton)
Table 146. Global DNA Repair Drugs Sales (Kilotons) Forecast by Application (2025-2030)
Table 147. Global DNA Repair Drugs Market Size Forecast by Application (2025-2030) & (M USD)
LIST OF FIGURES
Figure 1. Product Picture of DNA Repair Drugs
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global DNA Repair Drugs Market Size (M USD), 2019-2030
Figure 5. Global DNA Repair Drugs Market Size (M USD) (2019-2030)
Figure 6. Global DNA Repair Drugs Sales (Kilotons) & (2019-2030)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. DNA Repair Drugs Market Size by Country (M USD)
Figure 11. DNA Repair Drugs Sales Share by Manufacturers in 2023
Figure 12. Global DNA Repair Drugs Revenue Share by Manufacturers in 2023
Figure 13. DNA Repair Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market DNA Repair Drugs Average Price (USD/Ton) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by DNA Repair Drugs Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global DNA Repair Drugs Market Share by Type
Figure 18. Sales Market Share of DNA Repair Drugs by Type (2019-2024)
Figure 19. Sales Market Share of DNA Repair Drugs by Type in 2023
Figure 20. Market Size Share of DNA Repair Drugs by Type (2019-2024)
Figure 21. Market Size Market Share of DNA Repair Drugs by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global DNA Repair Drugs Market Share by Application
Figure 24. Global DNA Repair Drugs Sales Market Share by Application (2019-2024)
Figure 25. Global DNA Repair Drugs Sales Market Share by Application in 2023
Figure 26. Global DNA Repair Drugs Market Share by Application (2019-2024)
Figure 27. Global DNA Repair Drugs Market Share by Application in 2023
Figure 28. Global DNA Repair Drugs Sales Growth Rate by Application (2019-2024)
Figure 29. Global DNA Repair Drugs Sales Market Share by Region (2019-2024)
Figure 30. North America DNA Repair Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 31. North America DNA Repair Drugs Sales Market Share by Country in 2023
Figure 32. U.S. DNA Repair Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 33. Canada DNA Repair Drugs Sales (Kilotons) and Growth Rate (2019-2024)
Figure 34. Mexico DNA Repair Drugs Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe DNA Repair Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 36. Europe DNA Repair Drugs Sales Market Share by Country in 2023
Figure 37. Germany DNA Repair Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 38. France DNA Repair Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 39. U.K. DNA Repair Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 40. Italy DNA Repair Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 41. Russia DNA Repair Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 42. Asia Pacific DNA Repair Drugs Sales and Growth Rate (Kilotons)
Figure 43. Asia Pacific DNA Repair Drugs Sales Market Share by Region in 2023
Figure 44. China DNA Repair Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 45. Japan DNA Repair Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 46. South Korea DNA Repair Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 47. India DNA Repair Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 48. Southeast Asia DNA Repair Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 49. South America DNA Repair Drugs Sales and Growth Rate (Kilotons)
Figure 50. South America DNA Repair Drugs Sales Market Share by Country in 2023
Figure 51. Brazil DNA Repair Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 52. Argentina DNA Repair Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 53. Columbia DNA Repair Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 54. Middle East and Africa DNA Repair Drugs Sales and Growth Rate (Kilotons)
Figure 55. Middle East and Africa DNA Repair Drugs Sales Market Share by Region in 2023
Figure 56. Saudi Arabia DNA Repair Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 57. UAE DNA Repair Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 58. Egypt DNA Repair Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 59. Nigeria DNA Repair Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 60. South Africa DNA Repair Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 61. Global DNA Repair Drugs Sales Forecast by Volume (2019-2030) & (Kilotons)
Figure 62. Global DNA Repair Drugs Market Size Forecast by Value (2019-2030) & (M USD)
Figure 63. Global DNA Repair Drugs Sales Market Share Forecast by Type (2025-2030)
Figure 64. Global DNA Repair Drugs Market Share Forecast by Type (2025-2030)
Figure 65. Global DNA Repair Drugs Sales Forecast by Application (2025-2030)
Figure 66. Global DNA Repair Drugs Market Share Forecast by Application (2025-2030)
Figure 1. Product Picture of DNA Repair Drugs
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global DNA Repair Drugs Market Size (M USD), 2019-2030
Figure 5. Global DNA Repair Drugs Market Size (M USD) (2019-2030)
Figure 6. Global DNA Repair Drugs Sales (Kilotons) & (2019-2030)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. DNA Repair Drugs Market Size by Country (M USD)
Figure 11. DNA Repair Drugs Sales Share by Manufacturers in 2023
Figure 12. Global DNA Repair Drugs Revenue Share by Manufacturers in 2023
Figure 13. DNA Repair Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market DNA Repair Drugs Average Price (USD/Ton) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by DNA Repair Drugs Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global DNA Repair Drugs Market Share by Type
Figure 18. Sales Market Share of DNA Repair Drugs by Type (2019-2024)
Figure 19. Sales Market Share of DNA Repair Drugs by Type in 2023
Figure 20. Market Size Share of DNA Repair Drugs by Type (2019-2024)
Figure 21. Market Size Market Share of DNA Repair Drugs by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global DNA Repair Drugs Market Share by Application
Figure 24. Global DNA Repair Drugs Sales Market Share by Application (2019-2024)
Figure 25. Global DNA Repair Drugs Sales Market Share by Application in 2023
Figure 26. Global DNA Repair Drugs Market Share by Application (2019-2024)
Figure 27. Global DNA Repair Drugs Market Share by Application in 2023
Figure 28. Global DNA Repair Drugs Sales Growth Rate by Application (2019-2024)
Figure 29. Global DNA Repair Drugs Sales Market Share by Region (2019-2024)
Figure 30. North America DNA Repair Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 31. North America DNA Repair Drugs Sales Market Share by Country in 2023
Figure 32. U.S. DNA Repair Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 33. Canada DNA Repair Drugs Sales (Kilotons) and Growth Rate (2019-2024)
Figure 34. Mexico DNA Repair Drugs Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe DNA Repair Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 36. Europe DNA Repair Drugs Sales Market Share by Country in 2023
Figure 37. Germany DNA Repair Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 38. France DNA Repair Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 39. U.K. DNA Repair Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 40. Italy DNA Repair Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 41. Russia DNA Repair Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 42. Asia Pacific DNA Repair Drugs Sales and Growth Rate (Kilotons)
Figure 43. Asia Pacific DNA Repair Drugs Sales Market Share by Region in 2023
Figure 44. China DNA Repair Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 45. Japan DNA Repair Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 46. South Korea DNA Repair Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 47. India DNA Repair Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 48. Southeast Asia DNA Repair Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 49. South America DNA Repair Drugs Sales and Growth Rate (Kilotons)
Figure 50. South America DNA Repair Drugs Sales Market Share by Country in 2023
Figure 51. Brazil DNA Repair Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 52. Argentina DNA Repair Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 53. Columbia DNA Repair Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 54. Middle East and Africa DNA Repair Drugs Sales and Growth Rate (Kilotons)
Figure 55. Middle East and Africa DNA Repair Drugs Sales Market Share by Region in 2023
Figure 56. Saudi Arabia DNA Repair Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 57. UAE DNA Repair Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 58. Egypt DNA Repair Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 59. Nigeria DNA Repair Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 60. South Africa DNA Repair Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 61. Global DNA Repair Drugs Sales Forecast by Volume (2019-2030) & (Kilotons)
Figure 62. Global DNA Repair Drugs Market Size Forecast by Value (2019-2030) & (M USD)
Figure 63. Global DNA Repair Drugs Sales Market Share Forecast by Type (2025-2030)
Figure 64. Global DNA Repair Drugs Market Share Forecast by Type (2025-2030)
Figure 65. Global DNA Repair Drugs Sales Forecast by Application (2025-2030)
Figure 66. Global DNA Repair Drugs Market Share Forecast by Application (2025-2030)
